These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 17169557)

  • 21. Discovery of novel phosphorus-containing steroids as selective glucocorticoid receptor antagonist.
    Jiang W; Fiordeliso JJ; Allan G; Linton O; Tannenbaum P; Xu J; Zhu P; Gunnet J; Demarest K; Lundeen S; Sui Z
    Bioorg Med Chem Lett; 2007 Mar; 17(5):1471-4. PubMed ID: 17258455
    [TBL] [Abstract][Full Text] [Related]  

  • 22. 7-aryl 1,5-dihydro-benzo[e][1,4]oxazepin-2-ones and analogs as non-steroidal progesterone receptor antagonists.
    Zhang P; Kern JC; Terefenko EA; Fensome A; Unwalla R; Zhang Z; Cohen J; Berrodin TJ; Yudt MR; Winneker RC; Wrobel J
    Bioorg Med Chem; 2008 Jul; 16(13):6589-600. PubMed ID: 18504132
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Progesterone receptor antagonists.
    Spitz IM
    Curr Opin Investig Drugs; 2006 Oct; 7(10):882-90. PubMed ID: 17086932
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 5-Aryl indanones and derivatives as non-steroidal progesterone receptor modulators.
    Kern JC; Terefenko E; Trybulski E; Berrodin TJ; Cohen J; Winneker RC; Yudt MR; Zhang Z; Zhu Y; Zhang P
    Bioorg Med Chem Lett; 2009 Dec; 19(23):6666-9. PubMed ID: 19864132
    [TBL] [Abstract][Full Text] [Related]  

  • 25. 5-(3-Cyclopentyl-2-thioxo-2,3-dihydro-1H-benzimidazol-5-yl)-1-methyl-1H-pyrrole-2-carbonitrile: A novel, highly potent, selective, and orally active non-steroidal progesterone receptor agonist.
    Zhang P; Terefenko E; Kern J; Fensome A; Trybulski E; Unwalla R; Wrobel J; Lockhead S; Zhu Y; Cohen J; Lacava M; Winneker RC; Zhang Z
    Bioorg Med Chem; 2007 Oct; 15(20):6556-64. PubMed ID: 17681796
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nonsteroidal progesterone receptor modulators: structure activity relationships.
    Winneker RC; Fensome A; Wrobel JE; Zhang Z; Zhang P
    Semin Reprod Med; 2005 Feb; 23(1):46-57. PubMed ID: 15714389
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Glucocorticoid receptor antagonists: new tools to investigate disorders characterized by cortisol hypersecretion.
    Peeters BW; Tonnaer JA; Groen MB; Broekkamp CL; van der Voort HA; Schoonen WG; Smets RJ; Vanderheyden PM; Gebhard R; Ruigt GS
    Stress; 2004 Dec; 7(4):233-41. PubMed ID: 16019588
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Steroidal lactones as inhibitors of 17beta-hydroxysteroid dehydrogenase type 5: chemical synthesis, enzyme inhibitory activity, and assessment of estrogenic and androgenic activities.
    Bydal P; Luu-The V; Labrie F; Poirier D
    Eur J Med Chem; 2009 Feb; 44(2):632-44. PubMed ID: 18472187
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CDB-4124 and its putative monodemethylated metabolite, CDB-4453, are potent antiprogestins with reduced antiglucocorticoid activity: in vitro comparison to mifepristone and CDB-2914.
    Attardi BJ; Burgenson J; Hild SA; Reel JR; Blye RP
    Mol Cell Endocrinol; 2002 Feb; 188(1-2):111-23. PubMed ID: 11911951
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synthesis and biological activity of novel nonsteroidal progesterone receptor antagonists based on cyclocymopol monomethyl ether.
    Hamann LG; Farmer LJ; Johnson MG; Bender SL; Mais DE; Wang MW; Crombie D; Goldman ME; Jones TK
    J Med Chem; 1996 Apr; 39(9):1778-89. PubMed ID: 8627601
    [TBL] [Abstract][Full Text] [Related]  

  • 31. 1,5-Dihydro-benzo[e][1,4]oxazepin-2(1H)-ones containing a 7-(5'-cyanopyrrol-2-yl) group as nonsteroidal progesterone receptor modulators.
    Kern JC; Terefenko EA; Fensome A; Unwalla R; Wrobel J; Cohen J; Zhu Y; Berrodin TJ; Yudt MR; Winneker RC; Zhang Z; Zhang P
    Bioorg Med Chem Lett; 2008 Sep; 18(18):5015-7. PubMed ID: 18722119
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The glucocorticoid agonist activities of mifepristone (RU486) and progesterone are dependent on glucocorticoid receptor levels but not on EC50 values.
    Zhang S; Jonklaas J; Danielsen M
    Steroids; 2007 Jun; 72(6-7):600-8. PubMed ID: 17509631
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mechanisms controlling agonist and antagonist potential of selective progesterone receptor modulators (SPRMs).
    Wardell SE; Edwards DP
    Semin Reprod Med; 2005 Feb; 23(1):9-21. PubMed ID: 15714386
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Molecular properties and preclinical pharmacology of JNJ-1250132, a steroidal progesterone receptor modulator that inhibits binding of the receptor to DNA in vitro.
    Allan GF; Palmer E; Musto A; Lai MT; Clancy J; Palmer S
    Steroids; 2006 Jul; 71(7):578-84. PubMed ID: 16597452
    [TBL] [Abstract][Full Text] [Related]  

  • 35. SAR studies of 6-(arylamino)-4,4-disubstituted-1-methyl-1,4-dihydro-benzo[d][1,3]oxazin-2-ones as progesterone receptor antagonists.
    Kern JC; Terefenko EA; Fensome A; Unwallla R; Wrobel J; Zhu Y; Cohen J; Winneker R; Zhang Z; Zhang P
    Bioorg Med Chem Lett; 2007 Jan; 17(1):189-92. PubMed ID: 17027272
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synthesis, in vitro progesterone receptors affinity of gadolinium containing mifepristone conjugates and estimation of binding sites in human breast cancer cells.
    Saha P; Hödl C; Strauss WS; Steiner R; Goessler W; Kunert O; Leitner A; Haslinger E; Schramm HW
    Bioorg Med Chem; 2010 Mar; 18(5):1891-8. PubMed ID: 20149664
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 5-benzylidene-1,2-dihydrochromeno[3,4-f]quinolines as selective progesterone receptor modulators.
    Zhi L; Tegley CM; Pio B; Edwards JP; Motamedi M; Jones TK; Marschke KB; Mais DE; Risek B; Schrader WT
    J Med Chem; 2003 Sep; 46(19):4104-12. PubMed ID: 12954062
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Discovery and preliminary SAR studies of a novel, nonsteroidal progesterone receptor antagonist pharmacophore.
    Pooley CL; Edwards JP; Goldman ME; Wang MW; Marschke KB; Crombie DL; Jones TK
    J Med Chem; 1998 Aug; 41(18):3461-6. PubMed ID: 9719599
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Medicine. Squelching progesterone's signal may prevent breast cancer.
    Marx J
    Science; 2006 Dec; 314(5804):1370. PubMed ID: 17138873
    [No Abstract]   [Full Text] [Related]  

  • 40. Discovery, chemistry, and reproductive pharmacology of asoprisnil and related 11beta-benzaldoxime substituted selective progesterone receptor modulators (SPRMs).
    Schubert G; Elger W; Kaufmann G; Schneider B; Reddersen G; Chwalisz K
    Semin Reprod Med; 2005 Feb; 23(1):58-73. PubMed ID: 15714390
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.